In line with these observations, FAK inhibitors decreased tumor growth and progression in mice PDAc models; furthermore, FAK inhibitors increased the sensitivity of PDAC cells to immunotherapy and render unresponsive tumors responsive to immunotherapy [202]. Here, PTK2 is linked to neoplasm.